New study seeks early warning signs for pregnancy complications in lupus patients
NCT ID NCT00198068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study is following 700 pregnant women with lupus or antiphospholipid syndrome across nine medical centers. Researchers are looking at specific proteins in the blood to see if they can predict serious pregnancy complications like fetal death, preterm delivery, or low birth weight. The goal is to find early markers that could help doctors manage these high-risk pregnancies better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify high-risk pregnancies early and improve monitoring for women with lupus or antiphospholipid syndrome.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct changes in care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Medical Center
COMPLETEDNew York, New York, 10032, United States
-
Guy's & St Thomas' NHS Foundation Trust
COMPLETEDLondon, SE1 7EH, United Kingdom
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
-
Johns Hopkins Hospital
COMPLETEDBaltimore, Maryland, 21287, United States
-
Mt. Sinai Hospital
RECRUITINGToronto, Ontario, M5G 2K4, Canada
-
NYU Langone Medical Center/Hospital for Joint Diseases
RECRUITINGNew York, New York, 10016, United States
-
Northwestern University
COMPLETEDChicago, Illinois, 60611, United States
-
Oklahoma Medical Research Foundation
COMPLETEDOklahoma City, Oklahoma, 73104, United States
-
University of Chicago
COMPLETEDChicago, Illinois, 60637, United States
-
University of Utah Salt Lake City
RECRUITINGSalt Lake City, Utah, 84132, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood platelet trends may reveal hidden risk in autoimmune disease
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test tell two forms of a clotting disorder apart?